Video Module

Innovative Paradigms for ART: Implementation Insights From an Expert Panel

Learn about new paradigms for ART, including two-drug ART regimens and injectable long-acting ART, as a panel of faculty debates the most pressing questions in the field, exploring what the data say, what clinicians think, and what patients want.

Chloe Orkin, MBChB, FRCP, MD
Program Director

Andrea Mantsios, PhD

Anthony M. Mills, MD

Omar Sued, MD, PhD

Babafemi Taiwo, MBBS

Video Module

Watch this on-demand Webcast of a CCO symposium at IAS 2019 to gain expert perspectives on evolving paradigms in ART, including two-drug regimens and long-acting injectable therapy. Learn from an international faculty panel as they engage in detailed discussions about novel ART approaches.

Chloe Orkin, MBChB, FRCP, MD
Program Director

Andrea Mantsios, PhD

Anthony M. Mills, MD

Omar Sued, MD, PhD

Babafemi Taiwo, MBBS Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: August 26, 2019 Expired: August 25, 2020

Part 1: New Paradigms for ART (16 mins)

Part 2: How Confident Are We With the Efficacy and Safety of Oral Two-Drug Regimens? (12 mins)

Part 3: Should I Consider Two-Drug Regimens for Most Patients in My Practice or for Just a Select Few? (6 mins)

Part 4: Is Baseline Resistance Testing Important for Two-Drug Regimens? (16 mins)

Part 5: LA ART: Will the Positive Clinical Trial Results Translate to Long-term Efficacy/Safety and Real-World Experience? (12 mins)

Part 6: What Have Patients’ Experiences Been on LA Therapy? (16 mins)

Part 7: What Are the Challenges of LA Injectable ART for the Provision of HIV Care? (13 mins)

Innovative Paradigms for ART: Implementation Insights From an Expert Panel

Innovative Paradigms for ART: Implementation Insights From an Expert Panel

Leaving the CCO site

Welcome to the CCO site.